These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9444110)

  • 1. Developing an anemia management protocol. Case study of the anemic patient.
    Hossli S
    ANNA J; 1997 Dec; 24(6):678-84; quiz 685. PubMed ID: 9444110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anemia management protocols and epoetin alfa administration: an algorithm approach. Case study of the anemic patient.
    Aiello J
    Nephrol Nurs J; 2002 Jun; 29(3):297-300. PubMed ID: 12164081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epoetin alfa: focus on maintaining a higher, stable, Hct. Case study of the anemic patient.
    Cohen JA; Brattich M
    ANNA J; 1997 Oct; 24(5):574-80; quiz 581. PubMed ID: 9392740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timely correction of anemia at the initiation of dialysis. Case study of the anemic patient.
    Breiterman-White R
    Nephrol Nurs J; 2002 Oct; 29(5):469-72. PubMed ID: 12434453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epoetin alfa use in patients with ESRD: an analysis of recent US prescribing patterns and hemoglobin outcomes.
    Collins AJ; Brenner RM; Ofman JJ; Chi EM; Stuccio-White N; Krishnan M; Solid C; Ofsthun NJ; Lazarus JM
    Am J Kidney Dis; 2005 Sep; 46(3):481-8. PubMed ID: 16129210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reengineering clinical operations in a medical practice to optimize the management of anemia of chronic kidney disease.
    Joy MS; Candiani C; Vaillancourt BA; Chin H; Hogan SL; Falk RJ
    Pharmacotherapy; 2007 May; 27(5):734-44. PubMed ID: 17461709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Administration of Epoetin alfa. Case study of the anemic patient.
    Cutler M
    ANNA J; 1997 Aug; 24(4):459-65; quiz 466. PubMed ID: 9325701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anemia management protocols: providing consistent hemoglobin outcomes.
    Michael M
    Nephrol Nurs J; 2005; 32(4):423-6. PubMed ID: 16180783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anemia management of adult hemodialysis patients in the US results: from the 1997 ESRD Core Indicators Project.
    Frankenfield D; Johnson CA; Wish JB; Rocco MV; Madore F; Owen WF
    Kidney Int; 2000 Feb; 57(2):578-89. PubMed ID: 10652035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anemia management practices in peritoneal dialysis patients. Case study of the anemic patient.
    MacCracken MA
    Nephrol Nurs J; 2001 Aug; 28(4):435-8. PubMed ID: 12143466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Operationalizing anemia management: organizing the program and coordinating the team.
    Krishnan M; Adams E
    Nephrol Nurs J; 2003 Oct; 30(5):567-70. PubMed ID: 14621634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An open-label, randomized, multicenter, controlled study of epoetin alfa for the treatment of anemia of chronic kidney disease in the long term care setting.
    Patel M; Thimons DG; Winston JL; Langholff W; McGowan T
    J Am Med Dir Assoc; 2012 Mar; 13(3):244-8. PubMed ID: 21450214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anemia management in patients with chronic conditions that affect erythropoiesis. Case study of the anemic patients.
    Deziel SM
    Nephrol Nurs J; 2002 Dec; 29(6):582-5. PubMed ID: 12596607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to design an anemia management protocol.
    Senger JM; Trenkle JA; St John WD
    ANNA J; 1998 Apr; 25(2):235-40. PubMed ID: 9801503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis between centrifuged hematocrit and "point-of-care" hemoglobin: impact on erythropoietin dosing.
    Marooney M
    ANNA J; 1998 Oct; 25(5):479-81. PubMed ID: 9887700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Once-monthly subcutaneous C.E.R.A. maintains stable hemoglobin control in patients with chronic kidney disease on dialysis and converted directly from epoetin one to three times weekly.
    Sulowicz W; Locatelli F; Ryckelynck JP; Balla J; Csiky B; Harris K; Ehrhard P; Beyer U;
    Clin J Am Soc Nephrol; 2007 Jul; 2(4):637-46. PubMed ID: 17699476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemoglobin and hematocrit: an analysis of clinical accuracy. Case study of the anemic patient.
    Keen ML
    ANNA J; 1998 Feb; 25(1):83-6. PubMed ID: 9543916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of epoetin alfa administered every 2 weeks to maintain hemoglobin and quality of life in anemic HIV-infected patients.
    Levine AM; Salvato P; Leitz GJ;
    AIDS Res Hum Retroviruses; 2008 Feb; 24(2):131-9. PubMed ID: 18284320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life in patients on dialysis: benefits of maintaining a hemoglobin of 11 to 12 g/dL.
    Gregory N
    Nephrol Nurs J; 2005; 32(3):307-10. PubMed ID: 16035472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reasons for producing guidelines on anemia of chronic renal failure: dialysis outcome quality initiative of the National Kidney Foundation.
    Triolo G; Canavese C; Di Giulio S
    Int J Artif Organs; 1998 Nov; 21(11):751-6. PubMed ID: 9894755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.